2C-B (Nexus): Effects, Risks, History, and Harm Reduction
2C-B is a synthetic psychedelic phenethylamine first made by Alexander Shulgin in 1974. This educational guide covers its pharmacology, history, effects, risks, dangerous interactions, and harm reduction. It is not medical advice and not a how-to. Most jurisdictions control it, and it concerns adults only.
What is 2C-B?
2C-B (4-bromo-2,5-dimethoxyphenethylamine) is a synthetic psychedelic in the phenethylamine family, structurally related to mescaline. The American chemist Alexander Shulgin first synthesized it in 1974. It acts mainly on serotonin 5-HT2A receptors, although its precise receptor activity is still debated in the research literature. Users describe a character that blends classic psychedelic and empathogenic qualities. This guide is educational and written for adults.
2C-B is commonly known as Nexus and is one of several 2C compounds Shulgin documented. It should not be confused with NBOMe substances, which are far more dangerous and have sometimes been sold as 2C-B. This page describes what 2C-B is and the risks around it. It does not provide doses, sourcing, preparation, or any instructions for use.
History and origins
Alexander Shulgin first synthesized 2C-B in 1974 and described its effects in the scientific literature in 1975, alongside the related compound 2C-D. In his 1991 book PiHKAL, written with Ann Shulgin, he listed 2C-B among a small group of phenethylamines he considered most significant. It moved from the laboratory into therapeutic and recreational settings over the following decades.
During the 1970s and 1980s, a small number of therapists in the United States and Europe used 2C-B in psychedelic-assisted psychotherapy, reporting that it helped lower psychological defenses. German psychiatrist Friederike Fischer and her husband reported using it with clients, sometimes in combination with MDMA. This early therapeutic use was informal and predates modern regulated clinical trials.
Cultural and recreational history
2C-B does not have a documented indigenous or ceremonial lineage like the mescaline-bearing cacti it resembles chemically. It is a modern laboratory compound. In the 1980s and early 1990s it was marketed in Germany and other European countries as a sexual enhancer under brand names such as Erox, and it was sold in Dutch smart shops as a legal alternative to ecstasy under the name Nexus.
As those legal windows closed, 2C-B spread through nightclub and rave scenes, where some people used it as an MDMA substitute. Contemporary users sometimes approach it in quiet, introspective, or spiritual settings, but this is a recent Western practice rather than an established tradition. Its history is short and tied to modern chemistry and drug policy.
What are its effects?
In general terms, 2C-B can produce visual changes such as brightened colors, geometric patterns, and shifting textures, along with emotional openness, a sense of physical energy, and altered perception of time. Many people report a mix of psychedelic and empathogenic qualities. The character shifts with the amount taken, with lighter experiences feeling more empathic and stronger ones feeling more intensely psychedelic and disorienting.
Physical sensations often include a noticeable body load, and nausea is common, particularly early in the experience. Effects generally last a moderate number of hours. Responses vary widely between individuals and settings. This guide intentionally gives no doses or measurements, because 2C-B has a relatively narrow range and higher amounts sharply increase the risk of frightening and physically dangerous effects.
Risks and dangers
Reported adverse effects of 2C-B include nausea, chills, anxiety, confusion, agitation, raised blood pressure, rapid heart rate, and elevated body temperature. At higher amounts, frightening hallucinations, seizures, hyperthermia, and, rarely, death have been described in the clinical toxicology literature. Psychologically, difficult experiences, panic, and lasting distress are possible, and the drug can worsen or unmask underlying psychiatric conditions.
A major hidden danger is substitution. Powders or pills sold as 2C-B have contained NBOMe compounds such as 25I-NBOMe, which are active at tiny amounts and have caused seizures, organ damage, and deaths. Because the two cannot be told apart by sight or taste, an untested sample is an unknown sample. Overheating and dehydration are added risks in crowded, hot party environments.
Contraindications and dangerous interactions
The most serious interaction risk is with other serotonergic drugs. Combining 2C-B with MAOIs, SSRIs and other antidepressants, or ayahuasca can trigger serotonin syndrome, a potentially fatal condition marked by agitation, high fever, muscle rigidity, and confusion. A published case linked 2C-B to serotonin syndrome with seizures and brain swelling. People taking any antidepressant or MAOI should treat this as a firm contraindication.
Other cautions include cardiovascular conditions and high blood pressure, since 2C-B raises heart rate and pressure, and a personal or family history of psychosis, mania, or schizophrenia. Mixing with stimulants adds cardiovascular strain and overheating risk. As a general harm reduction rule that applies to many substances, never combine central nervous system depressants such as alcohol, opioids, and benzodiazepines, since that combination can cause fatal respiratory depression. Pregnancy is another reason to avoid use entirely.
Harm reduction principles
For adults who will encounter these substances regardless, harm reduction lowers risk without endorsing use. Test substances with reagent kits or a drug-checking service, since 2C-B is frequently confused with far more dangerous NBOMe compounds. Pay attention to mindset and physical setting. Screen honestly for medical and psychiatric contraindications and for interacting medications before considering anything. Avoid mixing substances, and stay hydrated without overdoing water.
Have a trusted, sober person present rather than being alone, especially for stronger experiences. Give time afterward for reflection and integration, and seek professional support if a difficult experience lingers. None of this is medical advice. If someone shows a very high fever, seizures, chest pain, severe agitation, or unresponsiveness, call emergency services immediately and tell them what was taken. Getting help early saves lives.
Addiction potential and legal status
2C-B and related psychedelics are not generally linked to the physical dependence seen with opioids, alcohol, or benzodiazepines, and they are not usually described as compulsive. Tolerance rises quickly with repeated dosing, which limits back-to-back use. Psychological reliance and problematic patterns remain possible, and regular use can mask untreated mental health problems that deserve professional attention.
Legally, the United Nations placed 2C-B in Schedule II of the Convention on Psychotropic Substances in 2001. It is Schedule I in the United States, Schedule III in Canada, and controlled across most of Europe, Australia, and Latin America. Status varies by country and can change, so check current local law. This information is educational only, concerns adults, and is not for anyone under the legal age.
Frequently Asked Questions
Is 2C-B the same as MDMA or LSD?
No. 2C-B is a distinct synthetic phenethylamine that Alexander Shulgin first made in 1974. People describe its character as sitting somewhere between a classic psychedelic like LSD and an empathogen like MDMA, with visual and emotional components. It works mainly on serotonin 5-HT2A receptors. Its effects, duration, and risk profile differ from both of those substances.
Can 2C-B cause serotonin syndrome?
Yes, it can, especially when combined with other serotonergic drugs. A published case report documented serotonin syndrome with seizures and cerebral edema after 2C-B ingestion. The risk rises sharply if 2C-B is taken alongside MAOIs, SSRIs, other antidepressants, or ayahuasca. Serotonin syndrome is a medical emergency. Anyone showing agitation, high fever, rigidity, or confusion needs urgent care.
Is 2C-B legal?
In most countries, no. The United Nations placed 2C-B in Schedule II of the Convention on Psychotropic Substances in 2001. It is Schedule I in the United States, Schedule III in Canada, and controlled across most of Europe, Australia, and Latin America. Legal status varies by country and changes over time, so check current local law. This content concerns adults only.
Is 2C-B addictive?
Classic psychedelics and 2C-type compounds are not generally associated with the physical dependence seen with opioids, alcohol, or benzodiazepines, and they are not typically described as compulsive. Tolerance builds quickly with repeated use. Psychological reliance is still possible, and frequent use can mask untreated mental health issues. Low physical dependence does not mean the substance is safe.
Try Our Free Tools
Related topics: 2C-B, Nexus, phenethylamine psychedelic, Alexander Shulgin, harm reduction, serotonin syndrome, 5-HT2A receptor, psychedelic safety, NBOMe substitution risk
